SNGX

SNGX

USD

Soligenix Inc. Common Stock

$1.340-0.100 (-6.944%)

即時價格

Healthcare
生物科技
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$1.440

最高

$1.470

最低

$1.300

交易量

0.24M

公司基本面

市值

11.2M

行業

生物科技

國家

United States

交易統計

平均交易量

4.32M

交易所

NCM

貨幣

USD

52週範圍

最低 $1.09當前 $1.340最高 $6.23

相關新聞

PR Newswire

Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...

查看更多
Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma
PR Newswire

Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...

查看更多
Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
PR Newswire

Soligenix Announces Closing of $7.5 Million Public Offering

Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...

查看更多
Soligenix Announces Closing of $7.5 Million Public Offering
PR Newswire

Soligenix Announces Pricing of $7.5 Million Public Offering

Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...

查看更多
Soligenix Announces Pricing of $7.5 Million Public Offering